Sinai Health Receives $1-Million Donation to Revolutionize Cancer Diagnostics with Digital Pathology Integration

Nanostics and OncoHelix Partner to Launch AI-Driven Prostate Cancer Test in the Middle East

QIAGEN Secures European IVDR Certification for QIAstat-Dx Syndromic Testing Systems and Assays

Bayer and AskBio Partner with Belief BioMed to Develop Liver-Targeted Gene Therapies

Breakthrough Stem Cell Transplant Offers Insulin Independence for Type 1 Diabetes Patient

Tagrisso Gains FDA Approval for Treatment of Unresectable Stage III EGFR-Mutated Lung Cancer in the US

Tempus and Takeda Expand Partnership to Enhance Cancer Drug Development with Real-World Data

MedGenome and Twist Bioscience Partner to Launch HOPE for Rare Diseases Programme in India

Bioserve Biotechnologies Unveils PreciOnc: Revolutionizing At-Home Genetic Testing for Cancer Risk

Trinity Biotech Expands Maternal Health Portfolio with Acquisition of Metabolomics Diagnostics

Cepheid and Fleming Initiative Join Forces to Combat Antimicrobial Resistance

Qure.ai, Global Healthcare AI Leader, Raises $65 Million in Series D Funding Led by Lightspeed and 360 ONE Asset

CENTOGENE Unveils Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology

AmoyDx Pan Lung Cancer PCR Panel Approved as Companion Diagnostic for Repotrectinib in Advanced NSCLC

Lilly's Kisunla™ (donanemab-azbt) Gains Approval in Japan for Early Symptomatic Alzheimer's Disease Treatment